Larrey D, Fréneaux E, Babany G, Berson A, Amédée-Manesme O, Degott C, Bettan L, Paugam B, Pessayre D, Benhamou J P
Unité de Recherches de Physiopathologie Hépatique (INSERM U 24), Hôpital Beaujon, Clichy.
Gastroenterol Clin Biol. 1988 Mar;12(3):240-4.
Seven patients developed acute hepatitis after receiving Plethoryl for obesity for 4 to 16 weeks. Jaundice was generally associated with or preceded by asthenia, nausea and pruritus. Serum aminotransferase activities were markedly increased whereas alkaline phosphatase and gamma-glutamyltransferase activities were moderately elevated. There was no hepatic failure. In all cases, Plethoryl administration was promptly discontinued. In 6 cases, jaundice disappeared within 2 to 4 weeks, and recovery occurred within 2 to 5 months. In one case, however, jaundice disappeared within 12 weeks and recovery took 10 months.
7名患者在使用Plethoryl治疗肥胖4至16周后出现急性肝炎。黄疸通常伴有乏力、恶心和瘙痒,或在其之前出现。血清氨基转移酶活性显著升高,而碱性磷酸酶和γ-谷氨酰转移酶活性中度升高。未出现肝衰竭。所有病例均立即停用Plethoryl。6例患者的黄疸在2至4周内消失,2至5个月内康复。然而,有1例患者的黄疸在12周内消失,康复用了10个月。